GLP-1 agonists: Clinical Trials

3 trials of GLP-1 agonists, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 2 Phase 4, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 2
Not applicable1Completed 1

Follow GLP-1 agonists: new trials by email Literature Review of GLP-1 agonists trials Research Report on GLP-1 agonists

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial
GLP-1 agonists, Nutrition Counseling - Psoriatic Arthritis (PsA)
Phase 4RecruitingMedical College of Wisconsin222026-05-012026-08-10
Impact GLP-1 Agonists Following Bariatric
GLP-1 receptor agonist - Morbid Obesity, Metabolic Syndrome
Phase 4RecruitingUniversity of Missouri-Columbia1502024-02-012026-10-21
Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging
GLP-1 agonists, Cardiac MRI, Follow up by phone - Type II Diabetes
Not applicableCompletedCentre Hospitalier Universitaire Dijon422018-04-162026-02-04

Conditions studied

Arthritis, Psoriatic (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Hypertension (1)  ·  Metabolic Syndrome (1)  ·  Obesity, Morbid (1)  ·  Sleep Apnea, Obstructive (1)

Sponsors

Centre Hospitalier Universitaire Dijon (1)  ·  Medical College of Wisconsin (1)  ·  University of Missouri-Columbia (1)

Countries

United States (2)  ·  France (1)

Top investigators

Andrew Wheeler, MD (1)

Results publications

PMID 39900263